Effect of Occult Metastases on Survival in Node-Negative Breast Cancer
Donald L. Weaver,Takamaru Ashikaga,David N. Krag,Joan M. Skelly,Stewart J. Anderson,Seth P. Harlow,Thomas B. Julian,Eleftherios P. Mamounas,Norman Wolmark +8 more
TLDR
Occult metastases were an independent prognostic variable in patients with sentinel nodes that were negative on initial examination; however, the magnitude of the difference in outcome at 5 years was small, and these data do not indicate a clinical benefit of additional evaluation, including immunohistochemical analysis, of initially negative sentinel node in Patients with breast cancer.Abstract:
BackgroundRetrospective and observational analyses suggest that occult lymph-node metastases are an important prognostic factor for disease recurrence or survival among patients with breast cancer. Prospective data on clinical outcomes from randomized trials according to sentinel-node involvement have been lacking. MethodsWe randomly assigned women with breast cancer to sentinel-lymph-node biopsy plus axillary dissection or sentinel-lymph-node biopsy alone. Paraffin-embedded tissue blocks of sentinel lymph nodes obtained from patients with pathologically negative sentinel lymph nodes were centrally evaluated for occult metastases deeper in the blocks. Both routine staining and immunohistochemical staining for cytokeratin were used at two widely spaced additional tissue levels. Treating physicians were unaware of the findings, which were not used for clinical treatment decisions. The initial evaluation at participating sites was designed to detect all macrometastases larger than 2 mm in the greatest dimens...read more
Citations
More filters
Journal ArticleDOI
Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases
TL;DR: The results of the analyses suggest that disease progression to distant sites does not occur exclusively via the axillary lymph nodes, but rather that lymph node status serves as an indicator of the tumor's ability to spread.
Journal ArticleDOI
Deep learning as a tool for increased accuracy and efficiency of histopathological diagnosis
Geert Litjens,Clara I. Sánchez,Nadya Timofeeva,Meyke Hermsen,Iris D. Nagtegaal,Iringo Kovacs,Christina Hulsbergen van de Kaa,Peter Bult,Bram van Ginneken,Jeroen van der Laak +9 more
TL;DR: It is found that all slides containing prostate cancer and micro- and macro-metastases of breast cancer could be identified automatically while 30–40% of the slides containing benign and normal tissue could be excluded without the use of any additional immunohistochemical markers or human intervention.
Journal ArticleDOI
Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
Gary H. Lyman,Sarah Temin,Stephen B. Edge,Lisa A. Newman,Roderick R. Turner,Donald L. Weaver,Al B. Benson,Linda D. Bosserman,Harold J. Burstein,Hiram S. Cody,James A. Hayman,Cheryl L. Perkins,Donald A. Podoloff,Armando E. Giuliano +13 more
TL;DR: This guideline update reflects changes in practice since the 2005 guideline and recommends women without sentinel lymph node (SLN) metastases should not receive axillary lymph node dissection (ALND).
Journal ArticleDOI
Homeostatic chemokine receptors and organ-specific metastasis.
TL;DR: A model of 'cellular highways' is proposed to explain the effects of homeostatic chemokines on cancer cells and how they influence metastasis and the conclusion that molecular mechanisms control organ-specific metastasis is supported.
Journal ArticleDOI
Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO)
Marcos Ballester,Gil Dubernard,Fabrice Lecuru,Denis Heitz,Patrice Mathevet,Henri Marret,Denis Querleu,François Golfier,Eric Leblanc,Roman Rouzier,Emile Daraï +10 more
TL;DR: In this article, the authors did a prospective, multicentre cohort study to assess the detection rate and diagnostic accuracy of the sentinel lymph node (SLN) procedure in predicting the pathological pelvic-node status in patients with early stage endometrial cancer.
References
More filters
Book ChapterDOI
Nonparametric Estimation from Incomplete Observations
Edward L. Kaplan,Paul Meier +1 more
TL;DR: In this article, the product-limit (PL) estimator was proposed to estimate the proportion of items in the population whose lifetimes would exceed t (in the absence of such losses), without making any assumption about the form of the function P(t).
Journal ArticleDOI
Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease
Nathan Mantel,William Haenszel +1 more
TL;DR: In this paper, the role and limitations of retrospective investigations of factors possibly associated with the occurrence of a disease are discussed and their relationship to forward-type studies emphasized, and examples of situations in which misleading associations could arise through the use of inappropriate control groups are presented.
Book
Nonparametric Statistical Inference
TL;DR: Theoretical Bases for Calculating the ARE Examples of the Calculations of Efficacy and ARE Analysis of Count Data.
Journal ArticleDOI
Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases
TL;DR: The results of the analyses suggest that disease progression to distant sites does not occur exclusively via the axillary lymph nodes, but rather that lymph node status serves as an indicator of the tumor's ability to spread.
Journal ArticleDOI
American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer
Gary H. Lyman,Armando E. Giuliano,Mark R. Somerfield,Al B. Benson,Diane C. Bodurka,Harold J. Burstein,Alistair J. Cochran,Hiram S. Cody,Stephen B. Edge,Sharon Galper,James A. Hayman,Theodore Y. Kim,Cheryl L. Perkins,Donald A. Podoloff,Visa Haran Sivasubramaniam,Roderick R. Turner,Richard L. Wahl,Donald L. Weaver,Antonio C. Wolff,Eric P. Winer +19 more
TL;DR: A review of the available evidence demonstrates that, when performed by experienced clinicians, SNB appears to be a safe and acceptably accurate method for identifying early-stage breast cancer without involvement of the axillary lymph nodes.
Related Papers (5)
Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23–01): a phase 3 randomised controlled trial
Viviana Galimberti,Bernard F. Cole,Bernard F. Cole,Stefano Zurrida,Giuseppe Viale,Giuseppe Viale,Alberto Luini,Paolo Veronesi,Paolo Veronesi,Paola Baratella,Camelia Chifu,Manuela Sargenti,Mattia Intra,Oreste Gentilini,Mauro G. Mastropasqua,Giovanni Mazzarol,Samuele Massarut,Jean Rémi Garbay,Janez Zgajnar,Hanne Galatius,Angelo Recalcati,David Littlejohn,Monika Bamert,Marco Colleoni,Karen N. Price,Meredith M. Regan,Aron Goldhirsch,Alan S. Coates,Richard D. Gelber,Umberto Veronesi +29 more
American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer
Gary H. Lyman,Armando E. Giuliano,Mark R. Somerfield,Al B. Benson,Diane C. Bodurka,Harold J. Burstein,Alistair J. Cochran,Hiram S. Cody,Stephen B. Edge,Sharon Galper,James A. Hayman,Theodore Y. Kim,Cheryl L. Perkins,Donald A. Podoloff,Visa Haran Sivasubramaniam,Roderick R. Turner,Richard L. Wahl,Donald L. Weaver,Antonio C. Wolff,Eric P. Winer +19 more